Neomycin Sulfate
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Solaris Pharma Corporation | unknown | 1 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | generic | 1 | SUPPLYING |
| Chartwell RX, LLC | generic | 1 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg. — Recalling firm: Teva Pharmaceuticals USA Inc — Nationwide within the United States
CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC
